GlassScriptPhysician profile
Erin K Ly
NPI 1740638725
$28,132.38
in general payments reported to CMS, 2019-2025
8 companies · $25K in 2025
The $25K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $125 · 2024: $2,542 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $1,713 · Travel and Lodging: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,999.00 |
| Food and Beverage | $1,713.33 |
| Travel and Lodging | $1,297.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $27,410.57 | 2024-2025 | Tremfya, Stelara |
| Abbvie INC. | $176.74 | 2025 | |
| Phathom Pharmaceuticals, INC. | $129.56 | 2025 | Voquezna |
| Alnylam Pharmaceuticals INC. | $124.99 | 2023 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $123.03 | 2022 | |
| Erbe USA INC | $100.00 | 2025 | Vio3 |
| Pentax of America, INC. | $38.54 | 2025 | Pentax Medical, Inspira, C2 Cryoballoon |
| W. L. Gore & Associates, INC. | $28.95 | 2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.